A review of the management and outcome of patients admitted with cryptococcal meningitis at a regional hospital in KwaZulu-Natal province

References

• AIDS update 2016. Geneva, Switzerland: Joint United Nations programme on HIV/AIDS 2017.
   Google Scholar
• WHO. Global Report: UNAIDS Report on the AIDS epidemic, 2016. In: HIV/Aids. JUNPo, editor. Geneva: UNAIDS; 2016.
   Google Scholar
• Lehohla P. Mid-year population estimates, 2017. In: Stats SA, Pretoria: Government printer; 2017;1–20.
   Google Scholar
• Sengayi MM, Kielkowski D, Egger M, et al. Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study. S Afr Med J. 2017;107(10):871–6.
   PubMed Web of Science ®Google Scholar
• Harrison TS. The burden of HIV-associated cryptococcal disease. AIDS. 2009;23(4):531–2.
   PubMed Web of Science ®Google Scholar
• Lessells RJ, Mutevedzi PC, Newell ML, et al. Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S Afr Med J. 2011;101(4):251–2.
   PubMed Web of Science ®Google Scholar
• Adeyemi BO, Ross A. Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit. Afr J Prim Health Care Fam Med. 2014;6(1):1–6.
   Google Scholar
• Organisation WH. Ambitious treatment targets: Writing the final chapter of the AIDS epidemic In: UNAIDS, editor. Geneva: UNAIDS; 2014.
   Google Scholar
• Johnson LF, Moolla H, Dorrington RE. Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. South Afr J HIV Med. 2017;18(1):1–8.
   Web of Science ®Google Scholar
• Ndayishimiye E, Ross AJ. An audit of the screen-and-treat intervention to reduce cryptococcal meningitis in HIV-positive patients with low CD4 count. African Journal of Primary Health Care & Family Medicine. 2018;10(1):1–7.
   Web of Science ®Google Scholar
• National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. In: Health NDo, editor. Pretoria: National Department of Health; 2014. p. 119.
   Google Scholar
• Nagalingeswaran Kumarasamy PC, Nelesh PG, Lut Lynen, et al. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: December 2011. WHO. 2011;1–44.
   Google Scholar
• Govender N, Meintjes G, Bicanic T, et al. Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update. S Afr J HIV Med. 2013;14(2):76–86.
   Web of Science ®Google Scholar
• Walaza S. Cryptococcal screen-and-treat in Gauteng province, South Africa: Update from the first two years of implementation, 2012–2014. In: Health GDo, editor. Pretoria: Department of Health; 2014.
   Google Scholar
• Pongsai P, Atamasirikul K, Sungkanuparph S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Journal of Infection. 2010;60(6):474–7.
   PubMed Web of Science ®Google Scholar
• KZN. UNIVERSAL TEST AND TREAT “A Game Changer in HIV Prevention”. In: Health, editor. KwaZulu-Natal: KZNonline; 2016.
   Google Scholar
• Adeyemi BO, Ross A. Profile and acute mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa. S Afr Fam Pract. 2015;57(2):1–5.
   Web of Science ®Google Scholar
• Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. 2014.
   Google Scholar
• Mosha F, Muchunguzi V, Matee M, et al. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. BMC public health. 2013;13(1):1–7.
   PubMedGoogle Scholar
• Hawkins C, Chalamilla G, Okuma J, et al. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. Aids. 2011;25(9):1189–97.
   PubMed Web of Science ®Google Scholar
• Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. Aids. 2005;19(14):1525–34.
   PubMed Web of Science ®Google Scholar
• Corbett L, Raviglione M. Global burden of tuberculosis: past, present, and future. Tuberculosis and the Tubercle Bacillus: American Society of Microbiology; 2005. p. 3–12.
   Google Scholar
• Sharma S, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121(4):550–67.
   PubMed Web of Science ®Google Scholar
• Bucher HC, Griffith LE, Guyatt GH, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. Aids. 1999;13(4):501–7.
   PubMed Web of Science ®Google Scholar
• Del Amo J, Malin AS, Pozniak A, et al. Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology. Aids. 1999;13(10):1151–8.
   PubMed Web of Science ®Google Scholar
• Badri M, Ehrlich R, Wood R, et al. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001;5(3):225–32.
   PubMed Web of Science ®Google Scholar
• Lopez-Gatell H, Cole S, Hessol N, et al. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol. 2007;165(10):1134–42.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Nielsen K. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol. 2013;16(4):409–13.
   PubMed Web of Science ®Google Scholar
• Singh U, Aditi AP, Kapoor B, et al. Cryptococcal meningitis associated with tuberculosis in HIV infected patients. Indian J Tuberc. 2013;60(3):180–3.
   PubMedGoogle Scholar
• Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736–45.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370(26):2487–98.
   PubMed Web of Science ®Google Scholar
• Kambugu A, Meya DB, Rhein J, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46(11):1694–701.
   PubMed Web of Science ®Google Scholar
• Rolfes MA, Hullsiek KH, Rhein J, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis. 2014;59(11):1607–14.
   PubMed Web of Science ®Google Scholar
• Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis. 2009;49(5):702–9.
   PubMed Web of Science ®Google Scholar
• Zuger A, Louie E, Holzman RS, et al. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med. 1986;104(2):234–40.
   PubMed Web of Science ®Google Scholar
• DoH. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. In: Health, editor. Pretoria: South African Department of Health 2014;1–136.
   Google Scholar
• Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009;48(12):1775–83.
   PubMed Web of Science ®Google Scholar
• Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr. 2007;45(5):555–9.
   PubMed Web of Science ®Google Scholar
• Pongsai P, Atamasirikul K, Sungkanuparph S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Journal of Infection. 2010;60(6):474–7.
   PubMed Web of Science ®Google Scholar